ABVC Biopharma Inc (NASDAQ:ABVC)
| 0.6072 Delayed Data As of Mar 24 |  -0.0128 / -2.06%Today’s Change | 0.50 Today|||52-Week Range 3.13 | -2.85% Year-to-Date |
Latest ABVC News | Press Releases
No recent news for ABVC Biopharma Inc.
Today’s Trading
| Previous close | 0.62 |
| Today’s open | 0.64 |
| Day’s range | 0.61 - 0.64 |
| Volume | 37 |
| Average volume (3 months) | 578,704 |
| Market cap | -- |
Data as of 2:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -3.20% |
| Earnings growth (this year) | -1.96% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -26.34% |
| P/E ratio | NM |
| Price/Sales | 238.71 |
| Price/Book | 1.55 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 30, 2023 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $355.8K |
| Annual profit (last year) | -$12.8M |
| Net profit margin | -3,608.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Fremont, California |
Forecasts
